Valuation: Sopharma AD

Market Cap 1.91B 1.15B 999M 927M 855M 1.61B 110B 1.64B 10.98B 4.3B 54.52B 4.32B 4.22B 183B P/E 2024
12.3x
P/E 2025 7.16x
Enterprise Value 2.46B 1.47B 1.28B 1.19B 1.1B 2.07B 141B 2.1B 14.08B 5.51B 69.93B 5.54B 5.42B 235B EV / Sales 2024
0.66x
EV / Sales 2025 0.76x
Free-Float
31.06%
Yield 2024
2.68%
Yield 2025 -
1 day-1.56%
1 week+1.07%
Current month-2.07%
1 month-2.07%
3 months+11.18%
6 months+2.16%
Current year+32.67%
1 week 1.85
Extreme 1.85
1.93
1 month 1.84
Extreme 1.845
1.94
Current year 1.41
Extreme 1.41
2
1 year 1.23
Extreme 1.226
2
3 years 0.92
Extreme 0.9202
2
5 years 0.58
Extreme 0.5792
2
10 years 0.41
Extreme 0.4087
2
Manager TitleAgeSince
Chief Executive Officer 42 01/10/2000
Director of Finance/CFO - 01/01/2002
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 42 19/05/2010
Director/Board Member 63 19/05/2010
Director/Board Member 61 12/07/2011
Date Insider Type Main position Quantity % Market Cap.
9/30/20 A
Donev Investments Ad
BuyCompany 25,489 0.0189%
9/30/20 A Buy

Chief Executive Officer

12,000 0.0089%
9/29/20 A
Donev Investments Ad
BuyCompany 9,000 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
-1.56%+1.07%+50.81%+104.55% 1.15B
-0.31%+6.11%-21.95%-30.27% 15.97B
+0.57%+6.29%-27.25%-35.69% 7.28B
-3.89%+3.21%-18.22%-8.45% 6.51B
0.00%+4.32%-4.82%-29.25% 4.07B
+0.37%+4.11%-27.05%-46.30% 3.29B
+0.79%+1.97%+9.94%-31.82% 3.22B
+0.46%+3.22%-42.45%-23.15% 3.08B
+2.65%+7.10%-9.89%+5.73% 2.71B
+0.51%+4.46%+101.17% - 2.61B
Average -0.01%+4.34%+1.03%-10.52% 4.99B
Weighted average by Cap. -0.19%+5.43%-11.61%-23.43%

Financials

2024 2025
Net sales 2.14B 1.28B 1.12B 1.04B 956M 1.8B 123B 1.83B 12.27B 4.8B 60.93B 4.83B 4.72B 205B 2.63B 1.58B 1.37B 1.28B 1.18B 2.22B 151B 2.26B 15.1B 5.91B 74.97B 5.94B 5.81B 252B
Net income 77.85M 46.75M 40.61M 37.71M 34.78M 65.51M 4.46B 66.7M 446M 175M 2.22B 176M 172M 7.46B 134M 80.19M 69.66M 64.68M 59.65M 112M 7.66B 114M 766M 300M 3.8B 301M 295M 12.79B
Net Debt 444M 267M 232M 215M 198M 374M 25.47B 381M 2.55B 997M 12.65B 1B 980M 42.54B 541M 325M 282M 262M 242M 456M 31.04B 464M 3.1B 1.22B 15.41B 1.22B 1.19B 51.84B
Logo Sopharma AD
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
Employees
6,005
Date Price Change Volume
30/07/26 €1.890 -1.56% 58,824
29/07/26 €1.920 +1.05% 5,142
28/07/26 €1.900 0.00% 2,387
27/07/26 €1.900 0.00% 1,153
24/07/26 €1.900 +2.70% 30,240

Annual profits - Rate of surprise